Eco Animal Health to develop poultry vaccine with Ghent University

Writer, Stock Market Wire
Wednesday, February 13, 2019 - 14:48

Eco Animal Health said it had signed a poultry vaccine development licencing deal with Ghent University in Belgium.

The deal would allows Eco to further develop, register and commercialize a Clostridium perfringens vaccine for poultry based on antigens co-developed by academics at Ghent University and the University of Exeter.

At 2:48pm: (LON:EAH) Eco Animal Health Group PLC share price was 0p at 475p

Related content

Eco Animal Health gets regulatory nod in India for chicken egg treatment

Eco Animal Health Group said it had received a marketing authorisation from Indian authorities for use of its antimicrobial treatment in chickens laying eggs for...

Tue, 05/03/2019 - 14:09

ECO Animal Health signs second licensing deal with Poultry Diagnostic & Research Center

ECO Animal Health Group's subsidiary ECO Animal Health said Tuesday it had signed a second global exclusive licensing deal with the Poultry Diagnostic & Research...

Tue, 05/02/2019 - 10:48

Eco Animal Health profit up 15% on rising demand for pig, poultry treatments

Pharmaceuticals developer for animals Eco Animal Health booked a 15% rise in first-half profit, amid rising demand for its treatment for diseases in pigs and...

Mon, 10/12/2018 - 14:33

Which small cap pharma firms make a profit?

Typically people invest in small cap biotechnology and pharmaceutical stocks in the hope they can enjoy returns of many times their initial investment as the...

Thu, 15/11/2018 - 00:00

Eco Animal Health Group receives regulatory nod to market antimicrobial treatment in Vietnam

Eco Animal Health Group said Tuesday its subsidiary ECO Animal Health Limited had received approval from Vietnam regulators to market the use of an antimicrobial...

Tue, 28/08/2018 - 09:17